Last reviewed · How we verify

NCT04654559

Development of a Fever Detection Algorithm Based on Non-invasive Skin-based Sensor Values in Infants up to 18 Months of Age

Suspended NA Last updated 15 March 2024
What this trial tests

NA trial testing Unobtrusive data collection using wearable non-invasive sensors in Fever in 50 participants. Suspended.

Timeline
7 April 2020
Primary endpoint
30 March 2025
30 March 2025

Quick facts

Lead sponsorgreenTEG AG
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment50
Start date7 April 2020
Primary completion30 March 2025
Estimated completion30 March 2025
Sites2 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

greenTEG AG

Who can join

Adults 2 Weeks to 18 Months, any sex, with Fever. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fever of infants up to 18 months of age will be monitored in the hospital using the standard clinical methods and wearable research prototypes. These research prototypes will be measuring continuously and non-invasively skin based parameters, with which the feasibility of developing a fever detection algorithm will be investigated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fever

Currently open trials in the same condition.

Other greenTEG AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04654559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing